NCT06544473View on ClinicalTrials.gov

Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 29, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Turner SyndromeHypogonadism; OvarianHormone Replacement TherapyEstrogen Replacement TherapyEstrogen Deficiency
Interventions
DRUG

17-beta estradiol

Treatment with orally administered estrogen for 14 days

DRUG

17-beta estradiol

Treatment with transdermally administered estrogen for 14 days

Trial Locations (1)

8200

RECRUITING

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus

All Listed Sponsors
collaborator

University of Aarhus

OTHER

lead

Aarhus University Hospital

OTHER